Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Open in API
Filings indexed 323 across all filing types
Latest filing 2020-05-26 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
Dear Sir/Madam, Pursuant to regulation 7 (3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Please find herewith enclosed certificate dated 14th May, ....
Regulatory Filings
2020-05-26 English
Dear Sir, In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018, we are enclosing herewith a copy of the Certificate received from M/s Abhipra Capital ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2020. It is a compliance certificate from the Registrar and Share Transfer Agent confirming dematerialisation and listing of securities. The document is short (2565 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2020-05-21 English
This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct ....
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to the stock exchange informing about the closure of the trading window pursuant to insider trading regulations. It references the upcoming declaration of audited financial results for the quarter/year ended March 31, 2020, but does not contain any financial data or the results themselves. The document is an announcement related to regulatory compliance and trading restrictions, not a financial report or detailed filing. Given its brief nature and purpose, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2020-04-01 English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that our RTA informed regarding receipt of request for loss ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the loss of a share certificate and the request for issuance of a duplicate certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and replacement. The content is an official notification to the stock exchange about a shareholder's lost certificate and does not contain financial data, earnings, management discussion, or any report. It is an announcement related to shareholding but specifically about a lost share certificate and duplicate issuance, which does not fit into major shareholding notification or share issue categories. It is a regulatory compliance announcement related to share certificates under SEBI regulations. Given the nature and length of the document, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-02-24 English
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 11th February, ....
Regulatory Filings
2020-02-11 English
KOTHARI FERMENTATION & BIOCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve Pursuant to ....
Board/Management Information Classification · 95% confidence The document is a notice from Kothari Fermentation and Biochem Ltd. informing the Bombay Stock Exchange about an upcoming Board Meeting scheduled for February 11, 2020. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter/nine months ended December 31, 2019. The document references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements and mentions the closure of the trading window for insiders. The document is short (1943 characters) and serves as an announcement of a board meeting and upcoming financial results, not the financial results or report itself. Therefore, it is best classified as a Board/Management Information filing, which covers announcements related to board meetings and management activities.
2020-02-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.